Diabeloop
Brief
Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions
Profile
Founded in 2015, Diabeloop is a high-growth company that offers AI-based, personalized solutions to automate the treatment and the management of diabetes.
DBLG1 System, Diabeloop’s first medical device for automated insulin delivery (AID) and DBL-hu, its solution for highly unstable Type 1 diabetes management, are both CE-marked and being deployed in Europe.
Headquarters
